Thought Leader Select announces 50 Percent Annual Growth for 2010

New press release out today from the offices of Thought Leader Select:

Thought Leader Select announces 50 Percent Annual Growth for 2010


February 3, 2010 (CHAPEL HILL, NC)-Thought Leader Select, a Research Triangle, NC-based research and consulting company serving the biopharmaceutical and healthcare industries, announces 50 percent year-over-year growth for 2010.

Founded in 2006, Thought Leader Select is a specialty firm dedicated to strengthening industry collaborations with medical experts for the development of next generation medicines. The company’s practice area focuses on three aspects of working with key opinion leaders (KOLs) in the medical community:  identification and profiling, mapping, and engagement.

During the 2010 fiscal year, the company grew its revenues by 50 percent over fiscal year 2009, according to Kristen Smithwick, Vice President of Business Development, Marketing, and Strategic Planning.  “We had a very strong year in 2010, and we have solidified our position as one of the preeminent thought leader engagement companies in the marketplace,” stated Smithwick.

The company marked 2010 by generating a record 28 customized research assessments for 10 of the top 50 global biopharmaceutical companies (measured by revenue).  Thought Leader Select identified and profiled over 2500 KOLs in 30 countries. The medical experts represented multiple therapeutic areas and disease states, including neurology, ophthalmology, cardiology, endocrinology, and immunology.

Thought Leader Select used its industry-leading “deep profiling” methodology to identify and profile  traditional KOLs, such as physicians and medical researchers, non-traditional KOLs, such as certified diabetes educators, nurse practitioners, and physician assistants, as well as payer/market access KOLs, who specialize in advising biopharmaceutical companies as they seek reimbursement by third-party payers for their products, according to Clarissa Noureddine, senior research manager at the firm. “Last year (2010) was an awesome opportunity for us to show off our versatility—we were privileged to work on a variety of projects that will advance many new medicines for better public health,” stated Noureddine.

About Thought Leader Select

Thought Leader Select serves the biopharmaceutical and healthcare industries, as well as the medical community at large by assessing medical experts (known as “thought leaders” and “key opinion leaders”) within a host of therapeutic areas such as diabetes, oncology, and neurology.

Over two dozen of the top 50 global biopharmaceutical and healthcare companies count on our expertise when seeking to launch new medications for better public health, ensuring that they are collaborating with the right medical professionals for the right reasons—their skills and experiences.

Media Contact:
Brian Castle
Director of Global Marketing and Client Relations

More Posts

The MSL Playbook for Creating Value

By Mark Schoeman, General Manager Prior to and over the course of the pandemic, assessments have shown that scores for MSL teams have remained consistent.


Send Us A Message